Correlation Between Pieris Pharmaceuticals and Day One

Can any of the company-specific risk be diversified away by investing in both Pieris Pharmaceuticals and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pieris Pharmaceuticals and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pieris Pharmaceuticals and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Pieris Pharmaceuticals and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pieris Pharmaceuticals with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pieris Pharmaceuticals and Day One.

Diversification Opportunities for Pieris Pharmaceuticals and Day One

0.07

Correlation Coefficient

Pieris Pharmaceuticals  Day One

Significant diversification

The 3 months correlation between Pieris and Day is 0.07. Overlapping area represents the amount of risk that can be diversified away by holding Pieris Pharmaceuticals and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Pieris Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pieris Pharmaceuticals are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Pieris Pharmaceuticals i.e., Pieris Pharmaceuticals and Day One go up and down completely randomly.

Pair Corralation between Pieris Pharmaceuticals and Day One

Given the investment horizon of 90 days Pieris Pharmaceuticals is expected to under-perform the Day One. But the stock apears to be less risky and, when comparing its historical volatility, Pieris Pharmaceuticals is 1.32 times less risky than Day One. The stock trades about -0.02 of its potential returns per unit of risk. The Day One Biopharmaceuticals is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  1,350  in Day One Biopharmaceuticals on August 31, 2024 and sell it today you would earn a total of  22.00  from holding Day One Biopharmaceuticals or generate 1.63% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Pieris Pharmaceuticals  vs.  Day One Biopharmaceuticals

Pieris Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pieris Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Pieris Pharmaceuticals is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Day One Biopharmaceu

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Day One Biopharmaceuticals are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Day One is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with Pieris Pharmaceuticals and Day One

The main advantage of trading using opposite Pieris Pharmaceuticals and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pieris Pharmaceuticals position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.

The idea behind Pieris Pharmaceuticals and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.